NO985171L - Sulfonamidsubstituerte kondenserte 5-ringforbindelser, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene - Google Patents

Sulfonamidsubstituerte kondenserte 5-ringforbindelser, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene

Info

Publication number
NO985171L
NO985171L NO985171A NO985171A NO985171L NO 985171 L NO985171 L NO 985171L NO 985171 A NO985171 A NO 985171A NO 985171 A NO985171 A NO 985171A NO 985171 L NO985171 L NO 985171L
Authority
NO
Norway
Prior art keywords
compounds
sulfonamide
medicament
pharmaceutical preparations
preparations containing
Prior art date
Application number
NO985171A
Other languages
English (en)
Other versions
NO985171D0 (no
NO312546B1 (no
Inventor
Joachim Brendel
Uwe Gerlach
Hans Jochen Lang
Klaus Weidmann
Original Assignee
Hoechst Marion Roussel De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel De Gmbh filed Critical Hoechst Marion Roussel De Gmbh
Publication of NO985171D0 publication Critical patent/NO985171D0/no
Publication of NO985171L publication Critical patent/NO985171L/no
Publication of NO312546B1 publication Critical patent/NO312546B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/07—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/66—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19985171A 1997-11-10 1998-11-05 Sulfonamidsubstituerte kondenserte 5-ringforbindelser, deres anvendelse til fremstilling av medikament samt farmasöytiskepreparater inneholdende forbindelsene NO312546B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19749453A DE19749453A1 (de) 1997-11-10 1997-11-10 Sulfonamid-substituierte anellierte 5-Ring-Verbindungen, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen

Publications (3)

Publication Number Publication Date
NO985171D0 NO985171D0 (no) 1998-11-05
NO985171L true NO985171L (no) 1999-05-11
NO312546B1 NO312546B1 (no) 2002-05-27

Family

ID=7848065

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19985171A NO312546B1 (no) 1997-11-10 1998-11-05 Sulfonamidsubstituerte kondenserte 5-ringforbindelser, deres anvendelse til fremstilling av medikament samt farmasöytiskepreparater inneholdende forbindelsene

Country Status (29)

Country Link
US (1) US6015822A (no)
EP (1) EP0915087B1 (no)
JP (1) JP4331809B2 (no)
KR (1) KR19990045147A (no)
CN (1) CN1219533A (no)
AR (1) AR016006A1 (no)
AT (1) ATE236120T1 (no)
AU (1) AU742199B2 (no)
BR (1) BR9804995A (no)
CA (1) CA2253211C (no)
CZ (1) CZ363798A3 (no)
DE (2) DE19749453A1 (no)
DK (1) DK0915087T3 (no)
ES (1) ES2196456T3 (no)
HR (1) HRP980585B1 (no)
HU (1) HUP9802590A3 (no)
ID (1) ID21282A (no)
IL (1) IL126955A (no)
MY (1) MY115619A (no)
NO (1) NO312546B1 (no)
NZ (1) NZ332633A (no)
PL (1) PL329596A1 (no)
PT (1) PT915087E (no)
RU (1) RU2223951C2 (no)
SI (1) SI0915087T1 (no)
SK (1) SK283866B6 (no)
TR (1) TR199802270A2 (no)
TW (1) TW427970B (no)
ZA (1) ZA9810202B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100720844B1 (ko) 1998-07-08 2007-05-25 사노피-아벤티스 도이칠란트 게엠베하 황 치환된 설포닐아미노카복실산 n-아릴아미드, 이의 제조방법, 및 이를 함유하는 약제학적 제제
DE19929076A1 (de) * 1999-06-25 2000-12-28 Aventis Pharma Gmbh Indanylsubstituierte Benzolcarbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
WO2001046155A1 (en) * 1999-12-21 2001-06-28 Icagen, Inc. Potassium channel inhibitors
US6849634B2 (en) 2000-12-21 2005-02-01 Icagen Potassium channel inhibitors
KR100581703B1 (ko) 2001-12-12 2006-05-22 에프. 호프만-라 로슈 아게 아데노신 수용체 조절제로서의 벤조티오펜
US7119112B2 (en) * 2002-02-28 2006-10-10 Icagen, Inc. Sulfonamides as potassium channel blockers
US8115030B2 (en) * 2005-03-31 2012-02-14 Shionogi & Co., Ltd. Process for the preparation of sulfomate-carboxylate derivatives
CN101374808B (zh) * 2006-01-24 2011-05-25 伊莱利利公司 孕酮受体的吲哚磺酰胺调节剂
JP2009026126A (ja) * 2007-07-20 2009-02-05 Nec Electronics Corp 半導体装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1245663A (en) * 1983-03-04 1988-11-29 Yasuo Oshiro 1-nitrogen containing-7-hydroxy-indone derivatives and salts thereof
DE3623944A1 (de) * 1986-07-16 1988-02-11 Thomae Gmbh Dr K Neue benzolsulfonamido-indanylverbindungen, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3737195A1 (de) * 1987-11-03 1989-05-18 Bayer Ag Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
FR2639349B1 (fr) * 1988-11-23 1991-02-22 Sanofi Sa Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant
US5104890A (en) * 1989-03-28 1992-04-14 Fujisawa Pharmaceutical Company, Ltd. Benzopyran derivatives and processes for preparation thereof
US5877218A (en) * 1994-01-10 1999-03-02 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives

Also Published As

Publication number Publication date
ZA9810202B (en) 1999-05-10
CN1219533A (zh) 1999-06-16
DK0915087T3 (da) 2003-07-21
TW427970B (en) 2001-04-01
JP4331809B2 (ja) 2009-09-16
PT915087E (pt) 2003-08-29
NO985171D0 (no) 1998-11-05
PL329596A1 (en) 1999-05-24
DE19749453A1 (de) 1999-05-12
SK154598A3 (en) 1999-06-11
EP0915087A3 (de) 1999-07-21
SI0915087T1 (en) 2003-10-31
AU9139898A (en) 1999-05-27
HU9802590D0 (en) 1999-01-28
BR9804995A (pt) 2001-05-22
ES2196456T3 (es) 2003-12-16
HRP980585B1 (en) 2003-02-28
KR19990045147A (ko) 1999-06-25
NO312546B1 (no) 2002-05-27
AU742199B2 (en) 2001-12-20
AR016006A1 (es) 2001-05-30
EP0915087A2 (de) 1999-05-12
HUP9802590A2 (hu) 2000-04-28
ATE236120T1 (de) 2003-04-15
US6015822A (en) 2000-01-18
IL126955A0 (en) 1999-09-22
CA2253211C (en) 2009-04-14
RU2223951C2 (ru) 2004-02-20
SK283866B6 (sk) 2004-03-02
DE59807718D1 (de) 2003-05-08
CZ363798A3 (cs) 1999-05-12
MY115619A (en) 2003-07-31
TR199802270A2 (xx) 1999-05-21
EP0915087B1 (de) 2003-04-02
ID21282A (id) 1999-05-12
CA2253211A1 (en) 1999-05-10
JPH11236368A (ja) 1999-08-31
IL126955A (en) 2002-11-10
HRP980585A2 (en) 1999-06-30
HUP9802590A3 (en) 2001-08-28
NZ332633A (en) 2000-05-26

Similar Documents

Publication Publication Date Title
NO20032187D0 (no) Heterocyklylalkylpiperidinderivater, deres fremstilling samt preparater inneholdende forbindelsene
NO20010013L (no) Svovelsubstituerte sulfonylaminokarboksylsyre N-arylamider, deres fremstilling og anvendelse samt farmasöytiske preparater inneholdende forbindelsene
NO20032735L (no) Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene samt deres anvendelse
DK0789025T3 (da) Substituerede oxazolidinoner samt deres anvendelse som antibakterielle lægemidler
NO982580D0 (no) Nye taxoider, deres fremstilling samt farmas°ystiske preparater inneholdende taxoidene
DK1194403T3 (da) Indanylsubstituerede benzencarboxamider, fremgangsmåde til deres fremstilling, deres anvendelse som lægemiddel samt farmaceutiske tilberedninger med indhold deraf
DK1098874T3 (da) Benzocycloheptener, fremgangsmåder til deres fremstilling, farmaceutiske præparater, som indeholder disse, samt deres anvendelse til fremstilling af lægemidler
NO952493D0 (no) Pyrrolidin- og tiazolidinderivater, deres fremstilling samt medikamenter inneholdende forbindelsene
NO980273D0 (no) Femleddede heterocykluser med bifenylsulfonylsubstitusjon fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
HRP20040171A2 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
NO20016247L (no) Streptograminderivater, deres fremstilling samt preparater inneholdende derivatene
BR9811582B1 (pt) compostos derivados de 4-oxo-3,5-di-hidro-4h-piridazino[4,5-b]indol-1-acetamid a, medicamento e composição farmacêutica contendo os mesmos.
NO972433L (no) Substituerte 2-naftoylguanidiner, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
NO985171D0 (no) Sulfonamidsubstituerte kondenserte 5-ringforbindelser, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene
NO984476L (no) Sulfonamidsubstituerte kromaner, fremgangsmÕte for fremstilling derav, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene
NO980785D0 (no) Sulfonamidsubstituerte kondenserte 7-ringforbindelser, deres anvendelse som medikament samt farmasöytiske preparater inneholdende forbindelsene
DK1118610T3 (da) Benzensulfonamid-derivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne
NO985023L (no) Sulfonamidsubstituerte benzopyranderivater, fremgangsmÕter for deres fremstilling, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene
NO984475D0 (no) Sulfonamidsubstituerte kromaner, fremgangsmÕte for fremstilling derav, deres anvendelse som medikament samt farmas°ytiske preparater inneholdende forbindelsene
NO20024590D0 (no) Farmasöytiske preparater inneholdende oligosakkarider, de nye oligosakkarider samt deres fremstilling
DK1036090T3 (da) Echinocandinderivater, fremgangsmåde til deres fremstilling samt deres anvendelse som antifungale midler
NO972434D0 (no) Substituerte 1-naftoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
NO20020404L (no) Streptograminderivater, deres fremstilling samt preparater inneholdende derivatene
NO965370D0 (no) Substituerte kromanylsulfonyl(tio)ureaer, fremgangsmåter til deres fremstilling, deres anvendelse i farmasöytiske preparater samt farmasöytiske preparater inneholdende forbindelsene
DK225189A (da) Hydrazinocarbonyloxylabdaner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler